Table 2.
Baseline measurements vs. Week 8 of sertraline treatment for MDD group.
Baseline | Week 8 | n | Paired-t | p | |
---|---|---|---|---|---|
HDRS | 18.71 ± 3.22 | 10.24 ± 6.32 | 17 | 5.23 | <.001 |
F2-IsoP (ng/ml) | 0.047 ± 0.016 | 0.048 ± 0.019 | 13 | 0.07 | 0.94 |
IL-6 (pg/ml) | 0.96 ± 0.84 | 1.31 ± 0.98 | 17 | −2.37 | 0.03 |
IL-10 (pg/ml) | 0.27 ± 0.35 | 0.37 ± 0.62 | 17 | −0.19 | 0.85 |
IL-6/IL-10 | 12.92 ± 14.52 | 16.06 ± 16.19 | 17 | −1.62 | 0.13 |
Data are means ± SD of raw data. p values were calculated using paired-sample t-tests of log-transformed F2-IsoP and cytokine values. Certain sample sizes and baseline values for the MDD’s in this table differ from those in Table 1, because only MDD’s with both baseline and Week 8 data are included in Table 2.